• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Liminal Biosciences Inc (NQ: LMNL )

    N/A UNCHANGED
    Last Price Updated: 3:59 PM EDT, Sep 25, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 8.430 (1)
    Ask (Size) 8.500 (25)
    Prev. Close 8.500
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 31,042,560
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
    Via Benzinga
    Liminal BioSciences Stock Gains0% Today - Here's Why?
    Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Management, agreed to  
    Via Benzinga

    Performance

    More News

    Read More
    Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Liminal BioSciences Pulls Plug On Its Lead Development Program
    Via Benzinga
    Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada
    Via Benzinga
    Dow Rises 80 Points; MarketAxess Holdings Shares Slide
    Via Benzinga
    Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Liminal Biosciences Inc. (NASDAQ: LMNL) Leading the Way in Wednesday Trading Based on Percentage Gain
    Via Investor Brand Network
    Topics Derivatives
    Exposures Derivatives
    Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher
    Via Benzinga
    Why Is Freight Technologies (FRGT) Stock Up 25% Today?
    Via InvestorPlace
    Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
    Via InvestorPlace
    Markets Mixed; US Trade Deficit Widens In February
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Earnings Scheduled For March 15, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
    Via Benzinga
    Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
    Via Benzinga
    This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
    Via Benzinga
    Liminal BioSciences Outlines Plans To Further Develop Its Lead Compound
    Via Benzinga
    Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
    Via InvestorPlace
    Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022
    Via Benzinga
    The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Via Benzinga
    The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
    Via Benzinga
    The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.